Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course

Analysis of DU145 prostate cancer cells treated with the CDK inhibitor R547 at 3 doses for up to 24 hours. R547 exerts an antiproliferative effect on various cell lines. Results compared with those from PBMCs (GDS5266) and HCT116 cells (GDS5268) to identify pharmacodynamic biomarkers for R547.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 3 agent, 4 dose, 4 time sets

Platform:: GPL570
Series:: GSE15392
45 Samples

Download data: CEL

DataSet

Accession:: GDS5267

ID:: 5267

Supplemental Content

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from GEO Profiles

Supplemental Content

Related information

Important Links

Recent activity